Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations

High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR

Robert L. Shields, Angela K. Namenuk, Kyu Hong et al. · Journal of Biological Chemistry · 2001 · 1.2K citations · Full text

Pharmacy, Immunology, Molecular Biology +17

Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability

Hemant Sarin · Journal of Angiogenesis Research · 2010 · 554 citations · Full text

Engineering, Physiology, Biological Transport Phenomena +16

Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human

Dhaval K. Shah, Alison Betts · Journal of Pharmacokinetics and Pharmacodynamics · 2011 · 417 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice

Amit Garg, Joseph P. Balthasar · Journal of Pharmacokinetics and Pharmacodynamics · 2007 · 322 citations

Pharmacy, Pharmacokinetics, Physiology +9

In vivo biodistribution and accumulation of 89Zr in mice

Diane S. Abou, Thomas W. Ku, Peter Smith‐Jones · Nuclear Medicine and Biology · 2011 · 290 citations

Pharmacy, Nuclear Medicine, Pharmacokinetics +5